BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 9951685)

  • 1. Glycosylated and non-glycosylated recombinant human granulocyte colony-stimulating factor (rhG-CSF)--what is the difference?
    Höglund M
    Med Oncol; 1998 Dec; 15(4):229-33. PubMed ID: 9951685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the potency of glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factors in neutropenic and nonneutropenic CD rats.
    Nohynek GJ; Plard JP; Wells MY; Zerial A; Roquet F
    Cancer Chemother Pharmacol; 1997; 39(3):259-66. PubMed ID: 8996530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mobilization of CD34+ cells by glycosylated and nonglycosylated G-CSF in healthy volunteers--a comparative study.
    Höglund M; Smedmyr B; Bengtsson M; Tötterman TH; Cour-Chabernaud V; Yver A; Simonsson B
    Eur J Haematol; 1997 Sep; 59(3):177-83. PubMed ID: 9310126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inductive potential of recombinant human granulocyte colony-stimulating factor to mature neutrophils from x-irradiated human peripheral blood hematopoietic progenitor cells.
    Katsumori T; Yoshino H; Hayashi M; Takahashi K; Kashiwakura I
    Biol Pharm Bull; 2009 Nov; 32(11):1849-53. PubMed ID: 19881296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biosimilar G-CSF versus filgrastim and lenograstim in healthy unrelated volunteer hematopoietic stem cell donors.
    Farhan R; Urbanowska E; Zborowska H; Król M; Król M; Torosian T; Piotrowska I; Bogusz K; Skwierawska K; Wiktor-Jędrzejczak W; Snarski E
    Ann Hematol; 2017 Oct; 96(10):1735-1739. PubMed ID: 28801752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three types of recombinant human granulocyte colony-stimulating factor have equivalent biological activities in monkeys.
    Tanaka H; Tanaka Y; Shinagawa K; Yamagishi Y; Ohtaki K; Asano K
    Cytokine; 1997 May; 9(5):360-9. PubMed ID: 9195136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycosylation of recombinant human granulocyte colony stimulating factor: implications for stability and potency.
    Nissen C
    Eur J Cancer; 1994; 30A Suppl 3():S12-4. PubMed ID: 7535065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Actin polymerization in neutrophils from donors of peripheral blood stem cells: divergent effects of glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factor.
    Carulli G; Mattii L; Azzarà A; Brizzi S; Galimberti S; Zucca A; Benedetti E; Petrini M
    Am J Hematol; 2006 May; 81(5):318-23. PubMed ID: 16628714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Harvesting peripheral blood progenitor cells from healthy donors: retrospective comparison of filgrastim and lenograstim.
    Martino M; Console G; Irrera G; Callea I; Condemi A; Dattola A; Messina G; Pontari A; Pucci G; Furlò G; Bresolin G; Iacopino P; Morabito F
    J Clin Apher; 2005 Oct; 20(3):129-36. PubMed ID: 15892086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycosylation interference on RhoA activation: focus on G-CSF.
    Mattii L; Battolla B; Azzarà A; D'Urso G; Montali U; Petrini M
    Leuk Res; 2011 Feb; 35(2):265-7. PubMed ID: 20573400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug eruption caused by recombinant human G-CSF.
    Sasaki O; Yokoyama A; Uemura S; Fujino S; Inoue Y; Kohno N; Hiwada K
    Intern Med; 1994 Oct; 33(10):641-3. PubMed ID: 7530069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycosylated vs non-glycosylated granulocyte colony-stimulating factor (G-CSF)--results of a prospective randomised monocentre study.
    Bönig H; Silbermann S; Weller S; Kirschke R; Körholz D; Janssen G; Göbel U; Nürnberger W
    Bone Marrow Transplant; 2001 Aug; 28(3):259-64. PubMed ID: 11535993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of filgrastim and lenograstim in pediatric solid tumors.
    Sarı N; Dalva K; Ilhan IE
    Pediatr Hematol Oncol; 2013 Oct; 30(7):655-61. PubMed ID: 24050764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of lenograstim vs filgrastim administration following chemotherapy for peripheral blood stem cell (PBSC) collection: a retrospective study of 126 patients.
    Lefrère F; Bernard M; Audat F; Cavazzana-Calvo M; Belanger C; Hermine O; Arnulf B; Buzyn A; Varet B
    Leuk Lymphoma; 1999 Nov; 35(5-6):501-5. PubMed ID: 10609787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dose-finding study of lenograstim (glycosylated rHuG-CSF) for peripheral blood stem cell mobilization during postoperative adjuvant chemotherapy in patients with breast cancer. Lenograstim/Breast Cancer Study Group.
    Narabayashi M; Takeyama K; Fukutomi T; Tokuda Y; Tajima T; Okumura A; Chou T; Sano M; Makino H; Igarashi T; Sasaki Y; Imoto S; Ogura M; Morishima Y; Murai H; Okamoto S; Ikeda T; Kasai M; Yokozawa T; Tobinai K
    Jpn J Clin Oncol; 1999 Jun; 29(6):285-90. PubMed ID: 10418556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dose-finding study of glycosylated G-CSF (Lenograstim) combined with CHOP therapy for stem cell mobilization in patients with non-Hodgkin's lymphoma.
    Takeyama K; Ogura M; Morishima Y; Kasai M; Kiyama Y; Ohnishi K; Mitsuya H; Kawano F; Masaki Y; Sasaki T; Chou T; Yokozawa T; Tobinai K;
    Jpn J Clin Oncol; 2003 Feb; 33(2):78-85. PubMed ID: 12629058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of glycosylated and non-glycosylated G-CSFs, alone and in combination with other cytokines, on the growth of human progenitor cells.
    Pedrazzoli P; Gibelli N; Pavesi L; Preti P; Piolini M; Bertolini F; Robustelli della Cuna G
    Anticancer Res; 1996; 16(4A):1781-5. PubMed ID: 8712701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factor differently modifies actin polymerization in neutrophils.
    Zucca A; Brizzi S; Riccioni R; Azzarà A; Ghimenti M; Carulli G
    Clin Ter; 2006; 157(1):19-24. PubMed ID: 16669548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in functional activity and antigen expression of granulocytes primed in vivo with filgrastim, lenograstim, or pegfilgrastim.
    Ribeiro D; Veldwijk MR; Benner A; Laufs S; Wenz F; Ho AD; Fruehauf S
    Transfusion; 2007 Jun; 47(6):969-80. PubMed ID: 17524085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced dose of lenograstim is as efficacious as standard dose of filgrastim for peripheral blood stem cell mobilization and transplantation: a randomized study in patients undergoing autologous peripheral stem cell transplantation.
    Ataergin S; Arpaci F; Turan M; Solchaga L; Cetin T; Ozturk M; Ozet A; Komurcu S; Ozturk B
    Am J Hematol; 2008 Aug; 83(8):644-8. PubMed ID: 18508321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.